ID
25305
Beskrivning
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Nyckelord
Versioner (4)
- 2017-08-31 2017-08-31 -
- 2017-09-04 2017-09-04 -
- 2017-09-04 2017-09-04 -
- 2017-09-11 2017-09-11 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
31 augusti 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
pregnancy - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
pregnancy - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
Similar models
pregnancy - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
C0032976 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
Inga kommentarer